• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姑息性切除在不可治愈的胃癌患者中的应用。

Palliative resection in noncurative gastric cancer patients.

机构信息

Department of Surgery, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei, 11217, Taiwan.

出版信息

World J Surg. 2010 May;34(5):1015-21. doi: 10.1007/s00268-010-0467-7.

DOI:10.1007/s00268-010-0467-7
PMID:20145923
Abstract

BACKGROUND

Palliative resection for noncurable gastric cancer remains controversial, especially in the elderly. This retrospective study was designed to elucidate the clinicopathological factors and operative outcome in patients undergoing palliative gastric resection.

METHODS

From January 1988 to December 2008, 365 patients received palliative gastrectomy while 151 underwent exploratory laparotomy or gastrojejunostomy for noncurative gastric cancer at the Department of Surgery, Taipei Veterans General Hospital. Among the 365 patients, 182 patients (Group A) were aged 70 or less and 183 patients (Group B) were older than 70 years of age. Clinicopathological characteristics and surgical morbidity and mortality were analyzed.

RESULTS

The overall survival of patients who underwent resection was 10.2 months and that of patients without resection 4.48 months (p < 0.001). Compared to Group B, Group A patients were predominantly female (p < 0.001), had more advanced Borrmann-type tumors (p = 0.004), more diffuse type of Lauren classification (p < 0.001), and poorer cell differentiation (p < 0.001). The median overall survival was 10.5 months in Group A and 9.7 months in Group B (p = 0.854). The surgical morbidity was significant higher if the patients had comorbidity (p = 0.028). Both surgical morbidity (13.8% vs. 26.8%, p = 0.028) and mortality (0.5% vs. 6.0%, p < 0.0001) were significantly higher in Group B.

CONCLUSIONS

Gastric cancer is less aggressive in the elderly. Palliative gastrectomy can be performed in both younger and older patients, but younger patients tolerate surgery better. More attention should be paid to the perioperative care of the elderly.

摘要

背景

对于无法治愈的胃癌,姑息性切除术仍存在争议,尤其是在老年人中。本回顾性研究旨在阐明接受姑息性胃切除术患者的临床病理因素和手术结果。

方法

1988 年 1 月至 2008 年 12 月,外科部门对 365 名患有无法治愈胃癌的患者进行了姑息性胃切除术,而对 151 名患者进行了剖腹探查术或胃空肠吻合术。在 365 名患者中,182 名患者(A 组)年龄在 70 岁以下,183 名患者(B 组)年龄在 70 岁以上。分析了临床病理特征和手术发病率和死亡率。

结果

接受切除术的患者总体生存率为 10.2 个月,未接受切除术的患者为 4.48 个月(p<0.001)。与 B 组相比,A 组患者主要为女性(p<0.001),具有更晚期的 Borrmann 型肿瘤(p=0.004),更弥漫性的 Lauren 分类(p<0.001)和更差的细胞分化(p<0.001)。A 组的中位总生存期为 10.5 个月,B 组为 9.7 个月(p=0.854)。如果患者存在合并症,则手术发病率明显更高(p=0.028)。B 组的手术发病率(13.8%比 26.8%,p=0.028)和死亡率(0.5%比 6.0%,p<0.0001)均明显更高。

结论

老年人的胃癌侵袭性较小。姑息性胃切除术可在年轻和老年患者中进行,但年轻患者的手术耐受性更好。应更加关注老年人的围手术期护理。

相似文献

1
Palliative resection in noncurative gastric cancer patients.姑息性切除在不可治愈的胃癌患者中的应用。
World J Surg. 2010 May;34(5):1015-21. doi: 10.1007/s00268-010-0467-7.
2
[Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].[Borrmann Ⅳ型(全胃癌)的外科治疗与预后]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):185-189.
3
Palliative distal gastrectomy offers no survival benefit over gastrojejunostomy for gastric cancer with outlet obstruction: retrospective analysis of an 11-year experience.对于伴有幽门梗阻的胃癌患者,姑息性远端胃切除术与胃空肠吻合术相比,并无生存获益:一项11年经验的回顾性分析
World J Surg Oncol. 2014 Nov 29;12:364. doi: 10.1186/1477-7819-12-364.
4
Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre.≥75 岁老年胃癌患者行胃切除术的围手术期结局和生存:单一西方中心 18 年回顾性分析。
Langenbecks Arch Surg. 2021 Jun;406(4):1057-1069. doi: 10.1007/s00423-021-02116-w. Epub 2021 Mar 26.
5
Defining palliative surgery in patients receiving noncurative resections for gastric cancer.定义接受非根治性胃癌切除术患者的姑息性手术。
J Am Coll Surg. 2004 Jun;198(6):1013-21. doi: 10.1016/j.jamcollsurg.2004.02.007.
6
Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?IV期胃癌切除术后的结果;在特定患者亚组中是否观察到更好的结局?
J Surg Oncol. 2007 Feb 1;95(2):118-22. doi: 10.1002/jso.20328.
7
Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis.姑息性胃切除术与胃空肠吻合术治疗伴有出口梗阻的晚期胃癌:倾向评分匹配分析。
BMC Cancer. 2021 Feb 23;21(1):188. doi: 10.1186/s12885-021-07904-7.
8
Who will benefit from noncurative resection in patients with gastric cancer with single peritoneal metastasis?对于患有单一腹膜转移的胃癌患者,谁将从非根治性切除术中获益?
Am Surg. 2014 Feb;80(2):124-30. doi: 10.1177/000313481408000219.
9
Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients.对于胃腺癌,非治愈性胃切除术仅应在高度选择的患者中进行。
Ann Surg Oncol. 2013 Oct;20(11):3512-8. doi: 10.1245/s10434-013-3024-4. Epub 2013 Jun 14.
10
Prognostic significance of palliative gastrectomy in incurable advanced gastric cancer: a retrospective cohort study and meta-analysis.姑息性胃切除术在不可治愈的晚期胃癌中的预后意义:一项回顾性队列研究和荟萃分析
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2299-2312. doi: 10.26355/eurrev_202103_25262.

引用本文的文献

1
Are Palliative Interventions Worth the Risk in Advanced Gastric Cancer? A Systematic Review.姑息性干预措施在晚期胃癌中值得冒风险吗?一项系统评价。
J Clin Med. 2024 Sep 28;13(19):5809. doi: 10.3390/jcm13195809.
2
The prognostic role of palliative gastrectomy in advanced gastric cancer: a systematic review and meta-analysis.姑息性胃切除术对晚期胃癌预后的作用:系统评价和荟萃分析。
BMC Cancer. 2024 Sep 3;24(1):1096. doi: 10.1186/s12885-024-12860-z.
3
Who are optimal candidates for primary tumor resection in patients with metastatic gastric adenocarcinoma? A population-based study.

本文引用的文献

1
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.REAL-2和ML17032试验的荟萃分析:评估以卡培他滨为基础的联合化疗和以静脉输注5-氟尿嘧啶为基础的联合化疗用于治疗晚期食管胃癌。
Ann Oncol. 2009 Sep;20(9):1529-1534. doi: 10.1093/annonc/mdp047. Epub 2009 May 27.
2
Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy.制定腹腔镜辅助远端胃切除术的机构协议指南。
Ann Surg Oncol. 2009 Aug;16(8):2231-6. doi: 10.1245/s10434-009-0490-9. Epub 2009 May 9.
3
转移性胃腺癌患者中哪些是原发肿瘤切除术的最佳候选者?一项基于人群的研究。
PLoS One. 2024 Jan 24;19(1):e0292895. doi: 10.1371/journal.pone.0292895. eCollection 2024.
4
Application and progress of palliative therapy in advanced gastric carcinomas.姑息治疗在晚期胃癌中的应用与进展
Front Oncol. 2023 Mar 9;13:1104447. doi: 10.3389/fonc.2023.1104447. eCollection 2023.
5
Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis.胃癌姑息性胃切除术后的围手术期结局与生存:一项系统评价和荟萃分析
J Gastrointest Cancer. 2021 Mar;52(1):41-56. doi: 10.1007/s12029-020-00519-4. Epub 2020 Sep 22.
6
Gastrectomy for Metastatic Gastric Cancer: a 15-year Experience from a Developing Country.转移性胃癌的胃切除术:来自一个发展中国家的15年经验
Indian J Surg Oncol. 2019 Sep;10(3):527-534. doi: 10.1007/s13193-019-00943-4. Epub 2019 May 29.
7
Palliative Gastrectomy and Survival in Patients With Metastatic Gastric Cancer: A Propensity Score-Matched Analysis of a Large Population-Based Study.姑息性胃切除术与转移性胃癌患者的生存:一项基于大人群的倾向评分匹配分析。
Clin Transl Gastroenterol. 2019 May 22;10(5):1-8. doi: 10.14309/ctg.0000000000000048.
8
Role of Palliative Resection in Patients with Incurable Advanced Gastric Cancer Who are Unfit for Chemotherapy.姑息性切除在无法耐受化疗的晚期不可治愈胃癌患者中的作用。
World J Surg. 2019 Feb;43(2):571-579. doi: 10.1007/s00268-018-4816-2.
9
Staging and surgical approaches in gastric cancer: a clinical practice guideline.胃癌的分期与手术方法:临床实践指南
Curr Oncol. 2017 Oct;24(5):324-331. doi: 10.3747/co.24.3736. Epub 2017 Oct 25.
10
Surgical palliation of gastric outlet obstruction in advanced malignancy.晚期恶性肿瘤胃出口梗阻的外科姑息治疗。
World J Gastrointest Surg. 2016 Aug 27;8(8):545-55. doi: 10.4240/wjgs.v8.i8.545.
Risk factors and management of intra-abdominal infection after extended radical gastrectomy.
扩大根治性胃切除术后腹腔内感染的危险因素及管理
Am J Surg. 2008 Nov;196(5):741-5. doi: 10.1016/j.amjsurg.2007.11.031.
4
Inspection of safety and accuracy of D2 lymph node dissection in laparoscopy-assisted distal gastrectomy.腹腔镜辅助远端胃癌根治术中D2淋巴结清扫的安全性与准确性检查
World J Surg. 2008 Nov;32(11):2366-70. doi: 10.1007/s00268-008-9697-3. Epub 2008 Jul 31.
5
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.胃癌中的HER2:一种新的预后因素和新型治疗靶点。
Ann Oncol. 2008 Sep;19(9):1523-9. doi: 10.1093/annonc/mdn169. Epub 2008 Apr 25.
6
Capecitabine and oxaliplatin for advanced esophagogastric cancer.卡培他滨与奥沙利铂用于晚期食管胃癌
N Engl J Med. 2008 Jan 3;358(1):36-46. doi: 10.1056/NEJMoa073149.
7
Palliative management of gastric cancer.胃癌的姑息治疗
Surg Oncol. 2007 Dec;16(4):267-75. doi: 10.1016/j.suronc.2007.08.004. Epub 2007 Sep 18.
8
Palliative gastrectomy and chemotherapy for stage IV gastric cancer.IV期胃癌的姑息性胃切除术及化疗
J Cancer Res Clin Oncol. 2008 Feb;134(2):187-92. doi: 10.1007/s00432-007-0268-z. Epub 2007 Jul 5.
9
Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma.晚期(IV期)胃腺癌的姑息性手术
Hepatogastroenterology. 2007 Jan-Feb;54(73):298-303.
10
Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary?伴有远处转移的胃腺癌:是否有必要进行胃切除术?
Arch Surg. 2007 Feb;142(2):143-9; discussion 149. doi: 10.1001/archsurg.142.2.143.